IP Library Granted Patent US 12,723,271
Granted Patent B1
US 12,723,271 · App. 17/953,273 · Granted Sep 1, 2026

Modified nucleotides and nucleotide conjugates for polynucleotide synthesis

Inventors: Sebastian Palluk (Oakland, CA); Daniel Arlow (San Francisco, CA); Jeffrey George Bertram (Montebello, CA); Eric Estrin (Oakland, CA); Uwe Theo Bornscheuer (Greifswald, DE); Nico Dennis Fessner (Greifswald, DE); Christoffel Petrus Stephanus Badenhorst (Greifswald, DE); Jared Ellefson (El Cerrito, CA)
Assignee: Ansa Biotechnologies, Inc.
C12P19/34C12Q1/68C12Q2525/186
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,723,271
App. No.
17/953,273
Granted
Sep 1, 2026
Kind
B1
Abstract

Disclosed herein are improved methods for the de novo synthesis of nucleic acids by cyclic extension using a template-independent polymerase. Secondary structure formation in the nascent chain, which may inhibit extension reactions, is suppressed by the use of monomers with O-alkylated nucleobases that prevent Watson-Crick base pairing and/or other structures. After the synthesis is completed, the nucleobases can be converted back into native form by enzymatic removal of the alkyl groups.

Claims (27)

1 . A method of synthesizing a polynucleotide, comprising:

providing a polynucleotide comprising one or more alkylated nucleobases;

enzymatically removing one or more alkyl groups from said one or more alkylated nucleobases.

2 . The method of claim 1 , wherein providing said polynucleotide comprises:

contacting a precursor polynucleotide with a polymerase and a nucleotide comprising said alkylated nucleobase;

adding said nucleotide to the 3′ end of said precursor polynucleotide via said polymerase.

3 . The method of claim 1 , wherein providing said polynucleotide comprises:

contacting a precursor polynucleotide with a conjugate comprising a nucleotide covalently linked to a polymerase via a linker, wherein said nucleotide comprises said alkylated nucleobase; and

adding said nucleotide to the 3′ end of said precursor polynucleotide via said polymerase.

4 . The method of claim 3 , further comprising cleaving said linker after addition of said nucleotide to said precursor polynucleotide.

5 . The method of claim 2 , wherein said polymerase is a template independent polymerase.

6 . The method of claim 2 , wherein the nucleotide comprises a 2′ or 3′ modification.

7 . The method of claim 1 , wherein said removal of said one or more alkyl groups comprises contacting said polynucleotide with an enzyme capable of removing said one or more alkyl groups from said alkylated nucleobases.

8 . The method of claim 7 , wherein said enzyme is an alkyl transferase.

9 . The method of claim 3 , wherein the conjugate is represented by:

wherein

L 1 is selected from the group consisting of an optionally substituted C 1-4 alkylene chain, wherein 1-2 methylene units is optionally and independently replaced with —O—, —N(R a )—, —C(O)—, —S—, —S(O)—, —S(O) 2 —, or phenylene;

L 2 is a cleavable linker;

each R a is independently hydrogen or C 1-6 alkyl;

R 1 is C 1-6 alkyl, C 2-6 alkenyl, C 1-6 alkynyl, and —(CH 2 ) 0-3 Ph, wherein R 1 is optionally substituted with 1-6 instances of R 1a ;

each R 1a is independently selected from halogen, C 1-6 alkyl, —(CH 2 ) 0-3 OR 1b , —NO 2 , —N 3 , —OPO 2 OH, and —(CH 2 ) 0-3 NHR 1b ; and

each R 1b is independently selected from hydrogen, C 1-6 alkyl, —C(O)(C 1-6 alkyl), C 1-6 haloalkyl, —C(O)(C 1-6 haloalkyl), and —CH 2 OAc;

R is a ribose polyphosphate or deoxyribose polyphosphate; and

Pol is a polymerase.

10 . The method of claim 9 , wherein R 1 is C 1-3 alkyl.

11 . The method of claim 10 , wherein R 1 is methyl.

12 . The method of claim 9 , wherein the conjugate is

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2023
From: PALLUK, SEBASTIAN; ARLOW, DANIEL; BERTRAM, JEFFREY GEORGE; ESTRIN, ERIC; BORNSCHEUER, UWE THEO; FESSNER, NICO DENNIS; BADENHORST, CHRISTOFFEL PETRUS STEPHANUS; ELLEFSON, JARED
To: ANSA BIOTECHNOLOGIES, INC.
Reel/Frame 062952/0274 →
Continuity (1)
Provisional Application 63248166 · Sep 24, 2021
References Cited (34)
US 11254961B2 · Arlow et al. · 2022 [cited by applicant]
US 11624079B2 · Arlow et al. · 2023 [cited by applicant]
US 11732283B2 · Arlow et al. · 2023 [cited by applicant]
US 20070172860A1 · Hardin et al. · 2007 [cited by applicant]
US 20140308730A1 · Nikiforov et al. · 2014 [cited by applicant]
US 20150086981A1 · Cherkasov et al. · 2015 [cited by applicant]
US 20190112627A1 · Arlow et al. · 2019 [cited by applicant]
US 20190352327A1 · Wu et al. · 2019 [cited by applicant]
US 20220023820A1 · Strauss et al. · 2022 [cited by applicant]
US 20220205008A1 · Arlow et al. · 2022 [cited by applicant]
US 20220251617A1 · Arlow et al. · 2022 [cited by applicant]
US 20240401099A1 · Arlow et al. · 2024 [cited by applicant]
CN 101346472A · 2009 [cited by applicant]
JP 2009519041A · 2009 [cited by applicant]
JP 2010166918A · 2010 [cited by applicant]
WO 2004092331A2 · 2004 [cited by applicant]
WO 2006079061A2 · 2006 [cited by applicant]
WO 2007070542A2 · 2007 [cited by applicant]
WO 2007070572A2 · 2007 [cited by applicant]
WO 2014142981A1 · 2014 [cited by applicant]
WO 2015124955A1 · 2015 [cited by applicant]
WO 2017190018A1 · 2017 [cited by applicant]
WO 2017223517A1 · 2017 [cited by applicant]
WO 2024073349A2 · 2024 [cited by applicant]
Pongracz et al. “Synthesis of a 25 base oligonucleotide containing a styrene oxide modification at the O6 position of 2′-deoxyguanosine at a defined site and incorporation studies of the similarly modified 2′-deoxy guan… [cited by examiner]
Pon et al. “Modification of guanine bases by nucleoside phosphoramidite reagents during the solid phase synthesis of oligonucleotides” Nucleic Acids Research, vol. 13, No. 18, 1985. (Year: 1985). [cited by examiner]
Invitation to Pay Additional Fees for PCT/US2023/075020, mailed Mar. 7, 2024, 3 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2023/075020, mailed Apr. 23, 2024, 15 pages. [cited by applicant]
Chica et al., Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evoulution and rational design, Curr. Opin. Biotechnol. 16(4):378-84 (2005). [cited by applicant]
Singh et al., Protein Engineering Approaches in the Post-Genomic Era, Curr. Protein Pept. Sci., 18, 1-11 (2017). [cited by applicant]
Accession F6RGZ5. Jul. 27, 2011 (Year: 2011). [cited by applicant]
Bundy et al., Site-Specific Incorporation of p-Propargyloxyphenylalanine in a Cell-Free Environment for Direct Protein-Proteing Click Conjugation, Bioconjugate Chem, 21, 255-263 (2010). [cited by applicant]
Mccombs et al., Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry, AAPS J. Mar. 2015; 17(2): 339-351. Published on line Jan. 22, 2015, (2015). [cited by applicant]
PCT/US2017/039120 International Search Report and Written Opinion of mailed Oct. 12, 2017, 10 pages. [cited by applicant]